# A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060

> **NCT06897683** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** PF-07220060
- **DRUG:** Carbamazepine ER Tablet

## Key facts

- **NCT ID:** NCT06897683
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-21
- **Primary completion:** 2025-05-11
- **Final completion:** 2025-06-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06897683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06897683, "A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06897683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*